A recent study published in Nature Medicine offers evidence that genetics may be a direct cause of a specific form of Alzheimers disease and not merely a risk factor. While most patients currently do not have a clearly identified cause of this devastating illness, researchers found that people with two copies of the gene variant APOE4 are at extremely high risk of developing Alzheimers. The finding led them to recommend a new designation that takes this into account, which could lead to up to a fifth of Alzheimers patients being classified as having a genetically caused form of the disease. The shift eventually could lead to earlier diagnosis and treatment and affect the search for therapies. Reisa Sperling, a neurologist at Mass General Brigham and an author of the study, explains the importance of the findings. This interview has been edited for clarity and length.
Your study highlights a new, clearly identified genetic component to Alzheimers disease worthy of a new designation. Could you explain why thats significant?
Designating this form of Alzheimers disease means a group of people who are extremely likely I wont say absolutely, but extremely likely to develop Alzheimers could be treated earlier. This could really have an impact on preventing dementia.
The second thing is theres been an ongoing debate about whether Alzheimers disease has anything to do with amyloid plaques or not. And in this group, they begin to have buildup of amyloid plaques and tau tangles in their late 50s and early 60s, and the likelihood that they will develop symptoms of Alzheimers disease is extremely high. So it creates another link in our understanding of the disease process.
And finally, this is a bridge between the rare forms of genetically determined Alzheimers disease that are 100 percent penetrant and often affect people in their 40s and 50s. Those cases are often considered such a rarity that theyre not representative of Alzheimers disease. So people with two copies of APOE4 are a bit in the middle. This new study really suggests that their biomarkers are similar to what we see in these rare autosomal dominant diseases, and over 90 percent will develop Alzheimers pathology in their brains. It links the rare genetic forms of Alzheimers to what we call sporadic late-onset Alzheimers disease.
Part of this new classification would also make this type of Alzheimers one of the most common genetic disorders in the world. Are there benefits to having it classified that way?
I dont know that Im the best person to opine on that, but I certainly think there may be important reasons. For example, eventually getting insurance coverage for individuals who are below the age of 65 and need rapid evaluation and treatment for Alzheimers disease. Alzheimers disease often doesnt get diagnosed in these individuals because people think theyre too young. Additionally, they may not have insurance coverage for all of the medications required for treatment.
I do think it is important that this is recognized as one of the more common genetic links to Alzheimers disease and leads the way to one day being able to treat people who have a strong family history and genetic predisposition. Then we can really think about being aggressive and treating patients early.
Somehow, we have to turn these findings to instead of being scary for people being a sense of hope.
Weve known for a long time that there is a genetic component to Alzheimers disease. Is this one of the first studies to show such a specific genetic link?
No. As I mentioned there are these rare genes that weve known for more than 20 years that are very specific and cause Alzheimers disease at a much younger age. But this data really suggests that people who have two copies of this particular allele, APOE4, have such a high likelihood of developing Alzheimers disease.
So its not the first genetic link, but it is the first large study that convincingly says having two copies of this gene really increases the likelihood you will have Alzheimers disease. And its a more common gene; these other known genes are very rare. But with APOE4, its estimated that up to 15 percent of Alzheimers patients carry two copies of these alleles (although I will say that estimate is a little different across studies). It is much more common than these very rare autosomal dominant forms.
How common is it in the general population to have two copies of that gene?
Estimated, about 2 percent of the population, so its not that common. People having at least one copy of APOE4 is fairly common. Depending on which part of the world youre from, that can be up to 25 percent. But having two copies is still pretty rare.
There is still so much that we dont know about Alzheimers, but it does seem to be fueled by both genetic and environmental factors. In what ways does this research help push our understanding of the disease overall?
Thats a great question. And for me, this research really does provide support to both camps. One, the likelihood that people with these genes will develop amyloid plaque by the time theyre age 65 is somewhere between 75 and 95 percent. To me that suggests that it is genetically driven.
But there is a variability in the range of when people develop symptoms. And that suggests that there might be environmental or lifestyle factors that can make peoples brains more resilient, or conversely, more vulnerable. This research really supports both ideas that genetics is a major driver in Alzheimers disease, but you can modulate your risk of showing symptoms.
Would it be beneficial for people to know early on if they are carriers of these genes?
At this moment, I do not recommend that people who dont have symptoms get genetic testing or blood-based biomarker testing. I hope that recommendation will change greatly over the next few years.
There are large-scale clinical trials, including the one I run. Were recruiting people who have evidence of amyloid buildup, but dont yet have symptoms, and were recruiting a lot of people with a family history and have copies of APOE4. If that study and other studies like it succeed in treating people before they have symptoms, then I would recommend testing and trying to get treatment as soon as possible.
But we dont have that available right now, and I just think we dont yet know what to do with that information before people have symptoms.
If this new classification did occur, what areas of further research would you be most excited to pursue?
Number one for me is we need to be able to offer treatments to those patients. Right now, theres actually a black-box warning on some currently approved Alzheimers treatments that cautions treating people who have two copies of APOE4 because the risk of side effects is so great. I want to redouble my efforts to make sure we can offer disease-modifying medications in a safe way.
Number two is about the environment. Im quite interested in what it is that modulates whether people get symptoms sooner rather than later, with this buildup of amyloid thats genetically determined. How do we understand what factors were protective? Thats a very important area of research to help us understand what can modulate peoples risk of symptoms in the setting of a very strong genetic predisposition.
We talk about this in the study, but I think its also important to mention that these studies mostly observed white majority populations. And one of the things we desperately need to know is whether these findings are also true in more ethnic and racially diverse populations. There is some evidence that APOE4 might have a slightly different effect on amyloid in populations who come from communities of color.
Similarly, there are slight differences in the sex effects: Women APOE4 carriers have more likelihood of developing symptoms. I think its really important to get more information on representative populations, especially from communities of color, and really help us develop treatments that will work best for everybody.
For people who have Alzheimers or loved ones with Alzheimers, how do these findings offer hope or shed light on the disease?
This is another tool to be able to find people who have Alzheimers disease at an earlier stage and treat them earlier. My dad and my grandfather died of this disease, and Im a clinical neurologist. When I see people with symptoms, I think this is helping us learn about the underlying causes and will help us in accelerating to find good treatments.
I think it will both help the next generation of people who are likely to develop Alzheimers disease, but it will also help us treat people who already have Alzheimers disease symptoms because every little bit of information helps us develop better treatments for all.
I really hope this research doesnt have the effect of just scaring people. I hope it will instead say, These are important clues so that we can treat people earlier and hopefully prevent dementia.
Somehow, we have to turn these findings to instead of being scary for people being a sense of hope. I hope this means we will be able to find people and treat them before they develop symptoms.
By subscribing to this newsletter youre agreeing to our privacy policy
- Genetics colloquium: Chris Hittinger on the genomic making of metabolic niche breadth Sep. 11 - University of WisconsinMadison - September 15th, 2024 [September 15th, 2024]
- NIH Recognizes Yales Expertise in the Genetics of Rare Diseases - Yale School of Medicine - September 15th, 2024 [September 15th, 2024]
- SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing - PR Newswire - September 15th, 2024 [September 15th, 2024]
- Medicines race dilemma: What science says about genetics and health [PODCAST] - Kevin MD - September 15th, 2024 [September 15th, 2024]
- Researchers want to unlock genetics of the worlds tiniest animals - Popular Science - September 15th, 2024 [September 15th, 2024]
- Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout - Medical Device Network - September 15th, 2024 [September 15th, 2024]
- From farm to future: Technology in genetics - National Hog Farmer - September 2nd, 2024 [September 2nd, 2024]
- Editorial: Plant biotechnology and genetics for sustainable agriculture and global food security - Frontiers - September 2nd, 2024 [September 2nd, 2024]
- NSF Grant Brings Genetics Opportunities to Students in Alabama - Government Technology - September 2nd, 2024 [September 2nd, 2024]
- SBUs Ben Luft brings Lyme expertise to seminal paper on bacterial genetics and evolution - TBR News Media - September 2nd, 2024 [September 2nd, 2024]
- SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference - PR Newswire - September 2nd, 2024 [September 2nd, 2024]
- Singapores National Precision Medicine (NPM) Programme Engages Oxford Nanopore to Advance Understanding of the Genetics of Singapores Multi-Ethnic... - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - August 5th, 2024 [August 5th, 2024]
- Stopped clinical trials give evidence for the value of genetics - Nature.com - August 5th, 2024 [August 5th, 2024]
- What is DSD? Sex genetics and Olympic boxing controversy - Washington Examiner - August 5th, 2024 [August 5th, 2024]
- Fulgent Genetics Q2: Core Revenue Grows, but Profitability Is Still an Issue - The Motley Fool - August 5th, 2024 [August 5th, 2024]
- Viewpoint: Challenging yet another scientifically silly article claiming Black domination of sprinting and long distance running has nothing to do... - August 5th, 2024 [August 5th, 2024]
- Texas Company Trying To Resurrect Woolly Mammoths To Improve Genetics Of Bison - Cowboy State Daily - August 5th, 2024 [August 5th, 2024]
- Genetics confirms Berbers reached North Africa over 20,000 years ago; Arabs came in 7th Century CE - Down To Earth Magazine - August 5th, 2024 [August 5th, 2024]
- Unlocking plant genetics with telomere-to-telomere genome assemblies - Nature.com - July 26th, 2024 [July 26th, 2024]
- Carlo Ancelotti claims Jude Bellingham's 'genetics' are main reason behind Real Madrid & England superstar's meteoric rise to the top - Goal.com - July 26th, 2024 [July 26th, 2024]
- Genetics-based modeling estimates Idaho's wolf population was 1,150 in summer 2023 - Idaho Fish and Game - July 26th, 2024 [July 26th, 2024]
- Lung Cancer Research Foundation Joins Lung Cancer Advocacy Organizations and 23andMe to Launch Lung Cancer Genetics Study to Advance Research - PR... - July 26th, 2024 [July 26th, 2024]
- Fulgent Genetics (FLGT) Scheduled to Post Earnings on Friday - Defense World - July 26th, 2024 [July 26th, 2024]
- SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix - Financial Times - July 26th, 2024 [July 26th, 2024]
- LG Household & Health Care publishes research into the genetics of skin tone - GlobalCosmeticsNews - July 26th, 2024 [July 26th, 2024]
- Estonians gave their DNA to science now they're learning their genetic secrets - Nature.com - June 27th, 2024 [June 27th, 2024]
- Genetic clues to depression revealed in large study - PsyPost - June 27th, 2024 [June 27th, 2024]
- Move Over, Genghis Khan. Many Other Men Left Huge Genetic Legacies - Smithsonian Magazine - June 27th, 2024 [June 27th, 2024]
- 3X4 Genetics Selected as Partner for Preeminent Cancer Research and Treatment Nonprofit, The Metabolic Terrain ... - BioSpace - June 27th, 2024 [June 27th, 2024]
- NIFA Invests $6M in Animal Breeding, Genetics and Genomics | NIFA - National Institute of Food and Agriculture - June 27th, 2024 [June 27th, 2024]
- Arbel Harpak: Pursuing the Next Frontier in Genetics | Dell Medical School - Dell Medical School - June 27th, 2024 [June 27th, 2024]
- Coffee habits are partly linked to genetics, UC San Diego researchers say - NBC San Diego - June 27th, 2024 [June 27th, 2024]
- Advanced genetic tools help researchers ID new neurodevelopmental syndrome - Yale News - June 27th, 2024 [June 27th, 2024]
- Nutritious diet may protect against type 2 diabetes, regardless of genetics - News-Medical.Net - June 27th, 2024 [June 27th, 2024]
- Genome-wide association study identifies host genetic variants influencing oral microbiota diversity and metabolic ... - Nature.com - June 27th, 2024 [June 27th, 2024]
- Unlock the Secrets of Your DNA with Advanced Genetic Testing - North Forty News - June 27th, 2024 [June 27th, 2024]
- Modern and precise: Using gene editing to change the blueprint of an organism - Beef Magazine - June 27th, 2024 [June 27th, 2024]
- The 'gene deserts' unravelling the mysteries of disease - BBC.com - June 27th, 2024 [June 27th, 2024]
- UGA plant geneticists are tackling the climate crisis - Longview News-Journal - June 27th, 2024 [June 27th, 2024]
- Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA - TCTMD - June 27th, 2024 [June 27th, 2024]
- Bringing Gene Therapy to the Brain - The Scientist - June 27th, 2024 [June 27th, 2024]
- The importance of the paradise fish in evolutionary and behavioral genetics research - Phys.org - June 9th, 2024 [June 9th, 2024]
- What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing? - Yahoo Finance - June 9th, 2024 [June 9th, 2024]
- UW initiative aims to bring together social sciences and genetics - Wisbusiness.com - June 9th, 2024 [June 9th, 2024]
- Women have a higher genetic risk for PTSD, according to study by VCU and Swedish researchers - VCU News - June 9th, 2024 [June 9th, 2024]
- Genetics study points to potential treatments for restless leg syndrome - University of Cambridge news - June 9th, 2024 [June 9th, 2024]
- deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans - PR Newswire - June 9th, 2024 [June 9th, 2024]
- Genetic association mapping leveraging Gaussian processes | Journal of Human Genetics - Nature.com - June 9th, 2024 [June 9th, 2024]
- Minimally destructive hDNA extraction method for retrospective genetics of pinned historical Lepidoptera specimens ... - Nature.com - June 9th, 2024 [June 9th, 2024]
- Restless legs syndrome tied to 140 'hotspots' in the genome - Livescience.com - June 9th, 2024 [June 9th, 2024]
- Paired tumor-germline testing can enhance patient carewith guidance from genetics specialists - The Cancer Letter - June 9th, 2024 [June 9th, 2024]
- Improved functional mapping of complex trait heritability with GSA-MiXeR implicates biologically specific gene sets - Nature.com - June 9th, 2024 [June 9th, 2024]
- Genetic Risk Score Revolutionizes TNBC Prediction in Black Women - Targeted Oncology - June 9th, 2024 [June 9th, 2024]
- Gene variants and breast cancer risk in Black women - National Institutes of Health (NIH) (.gov) - June 9th, 2024 [June 9th, 2024]
- GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseases - News-Medical.Net - June 9th, 2024 [June 9th, 2024]
- Understanding the effect genetics have on Alzheimer's - Buffalo News - June 9th, 2024 [June 9th, 2024]
- 'Fossil viruses' embedded in the human genome linked to psychiatric disorders - Livescience.com - June 9th, 2024 [June 9th, 2024]
- Louisiana Sports Hall of Fame Profile: Ardoin's genetics provided gift for writing, and his versatility made him legendary - crescentcitysports.com - June 9th, 2024 [June 9th, 2024]
- Genes Link Sleep Patterns to Autism and Bipolar Disorder - Neuroscience News - June 9th, 2024 [June 9th, 2024]
- Tilapia genetics: a comparative trial between two strains in Brazil - The Fish Site - June 1st, 2024 [June 1st, 2024]
- New genetic cause of intellectual disability potentially uncovered in 'junk DNA' - Livescience.com - June 1st, 2024 [June 1st, 2024]
- Scientists identify gene that could lead to resilient 'pixie' corn - College of Agriculture and Life Sciences - June 1st, 2024 [June 1st, 2024]
- Veritas Genetics at the forefront of genomic screening with new studies presented at the European Society of Human ... - PR Newswire - June 1st, 2024 [June 1st, 2024]
- Researchers Discover Genetic Underpinnings of Inherited Condition Often Misdiagnosed as Hypothyroidism - InventUM - University of Miami - June 1st, 2024 [June 1st, 2024]
- Too much or too little: The impact of protein dosage on development - EurekAlert - June 1st, 2024 [June 1st, 2024]
- Hussman Institute Celebrates National DNA Day with Frost Science Museum - InventUM - University of Miami - June 1st, 2024 [June 1st, 2024]
- International treaty agreed on handling genetics in patents - Research Professional News - June 1st, 2024 [June 1st, 2024]
- Nebraska team identifies new genetic defect impacting cattle morbidity and meat quality - Beef Magazine - June 1st, 2024 [June 1st, 2024]
- Exploring the wonders of molecular biology - Drug Target Review - June 1st, 2024 [June 1st, 2024]
- 30 Years After Genetic Discovery, Huntingtons Patients Still Waiting - BioSpace - June 1st, 2024 [June 1st, 2024]
- Arn Anderson Bron Breakker Has Got His Dads Genetics, Will Be A Big Star - eWrestlingNews - June 1st, 2024 [June 1st, 2024]
- Genetic research: possibilities and risks Exaudi - Exaudi - June 1st, 2024 [June 1st, 2024]
- Study shows effect of 'interaction' on epigenetic marking in... - Parkinson's News Today - June 1st, 2024 [June 1st, 2024]
- The same genetic mutations behind gorillas' small penises may hinder fertility in men - Livescience.com - May 24th, 2024 [May 24th, 2024]
- Genetics reveals surprising origin of the German cockroach - Cosmos - May 24th, 2024 [May 24th, 2024]
- Genetics Reveals The Mysterious Origins Of The Cockroach - Forbes - May 24th, 2024 [May 24th, 2024]
- Optimizing genetics to advance controlled environment agriculture - AgriLife Today - AgriLife Today - May 24th, 2024 [May 24th, 2024]
- Genetics help combat illegal movement of feral swine - The Wildlife Society - May 24th, 2024 [May 24th, 2024]
- Tracking the cellular and genetic roots of neuropsychiatric disease - Yale News - May 24th, 2024 [May 24th, 2024]